Introduced
by
To impose a new coverage mandate that would require insurance companies to include coverage for orally administered chemotherapy in all their health insurance policies that cover any chemotherapy, without requiring any dollar limit, deductible or co-pay for these that does not apply to other treatments.
Referred to the Committee on Insurance
Reported without amendment
With the recommendation that the substitute (S-2) be adopted and that the bill then pass.
Amendment offered
To clarify details of a price cap the bill includes on the benefit it would mandate.
The amendment passed by voice vote
Passed in the Senate 36 to 1 (details)
Referred to the Committee on Insurance
